Terms: = Prostate cancer AND UBR5, EDD, 51366, ENSG00000104517, EDD1, KIAA0896, HYD, MGC57263, DD5, O95071, FLJ11310
8 results:
1. Targeting ubr5 inhibits postsurgical breast cancer lung metastases by inducing CDC73 and p53 mediated apoptosis.
Yu Z; Dong X; Song M; Xu A; He Q; Li H; Ouyang W; Chouchane L; Ma X
Int J Cancer; 2024 Feb; 154(4):723-737. PubMed ID: 37855385
[TBL] [Abstract] [Full Text] [Related]
2. A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer.
Ipsen MB; Sørensen EMG; Thomsen EA; Weiss S; Haldrup J; Dalby A; Palmfeldt J; Bross P; Rasmussen M; Fredsøe J; Klingenberg S; Jochumsen MR; Bouchelouche K; Ulhøi BP; Borre M; Mikkelsen JG; Sørensen KD
Oncogene; 2022 Sep; 41(37):4271-4281. PubMed ID: 35933519
[TBL] [Abstract] [Full Text] [Related]
3. BoxCar and shotgun proteomic analyses reveal molecular networks regulated by ubr5 in prostate cancer.
Yan Y; Zhou B; Lee YJ; You S; Freeman MR; Yang W
Proteomics; 2022 Feb; 22(4):e2100172. PubMed ID: 34897998
[TBL] [Abstract] [Full Text] [Related]
4. Ten-year treatment complication outcomes of radical prostatectomy vs external beam radiation vs brachytherapy for 1503 patients with intermediate risk prostate cancer.
Goy BW; Burchette R
Brachytherapy; 2021; 20(6):1083-1089. PubMed ID: 34090815
[TBL] [Abstract] [Full Text] [Related]
5. Activated Wnt/β-Catenin signaling contributes to E3 ubiquitin ligase edd-conferred docetaxel resistance in prostate cancer.
Bian P; Dou Z; Jia Z; Li W; Pan D
Life Sci; 2020 Aug; 254():116816. PubMed ID: 31472148
[TBL] [Abstract] [Full Text] [Related]
6. An Improved
Mangir N; Raza A; Haycock JW; Chapple C; Macneil S
In Vivo; 2018; 32(3):461-472. PubMed ID: 29695547
[TBL] [Abstract] [Full Text] [Related]
7. Expression of 25-hydroxyvitamin D-1alpha-hydroxylase (1alphaOHase, CYP27B1) splice variants in HaCaT keratinocytes and other skin cells: modulation by culture conditions and UV-B treatment in vitro.
Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3659-67. PubMed ID: 19667162
[TBL] [Abstract] [Full Text] [Related]
8. Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteins.
DeRoock IB; Pennington ME; Sroka TC; Lam KS; Bowden GT; Bair EL; Cress AE
Cancer Res; 2001 Apr; 61(8):3308-13. PubMed ID: 11309285
[TBL] [Abstract] [Full Text] [Related]
